Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already convey read-only, idempotent, open-world, and non-destructive, but the description adds substantial new behavioral context: graceful degradation ('if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return'), ambiguity handling (asserts nothing and returns figi_candidates), explicit unresolved reporting, source labeling of every identifier, and internal cascading lookups. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is well front-loaded with example queries and the core purpose, but the company-type explanation is a single sprawling parenthetical packing several behaviors (FIGI matching, ambiguity, ISIN mapping, degradation) into one dense block. It is thorough and nearly every sentence earns its place, but the wall-of-text structure hurts agent scannability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex two-type tool with no output schema, the description explains return identifiers (CIK, ticker, LEI, FIGI, RxCUI), data sources, ambiguity outcomes, and failure modes. The main gap is a clean statement of the response object's shape; mentions of figi_candidates and unresolved partially cover this but a structured return description would make it fully complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3, but the description adds critical value-param semantics: the 'ENTITY NAME ONLY' rule with a concrete bond example ('NEW YORK ST DORM AUTH' vs trailing security-class words matching nothing) and the accepted input forms (ticker, CIK, ISIN, name). The type param is also enriched by explaining exactly what each type returns.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries ('What's the ticker for…', 'find the CIK for…') and states the core function: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' This is a specific verb+resource that also distinguishes it from siblings like entity_profile and compare_entities by positioning it as the identity-resolution prerequisite.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

'Use FIRST whenever you have a name but need an ID' is an explicit trigger condition, reinforced by the example-query list and the efficiency note that it 'replaces 2-3 manual lookups.' It does not explicitly name alternatives or state when-not-to-use cases, so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools occupy nearly identical roles: ask_pipeworx and ask_pipeworx_beta are described as functionally identical right now, ask_pipeworx_grounded and deep_research are overlapping query modes, and ai_visibility_check / scan_competitor_ai_presence / discover_tools / suggest_questions all blur into discovery or visibility tasks. The two actual BioStudies tools are clear, but they are buried in a server dominated by Pipeworx meta-tools.

Naming Consistency3/5

All tool names use snake_case, and many follow a verb_noun shape such as search_studies, get_study, and discover_tools. However, the convention is inconsistent across the set: noun-first names like entity_profile and polymarket_edges, brand-prefixed names like pipeworx_feedback, and verb-first product names like ask_pipeworx all coexist, making the pattern harder to predict.

Tool Count2/5

33 tools is well into the too-many range, and the count is especially inappropriate for a server named Biostudies since only search_studies and get_study actually belong to that domain. The rest form a sprawling general-purpose data-research platform that appears to have been merged into one server without a clear scope.

Completeness3/5

For the BioStudies-specific surface, search_studies and get_study provide reasonable read-only coverage for the EBI archive. But as the broader research platform the other 31 tools imply, the set is hard to evaluate for completeness because most actual data access is delegated to Pipeworx's hidden 5,718 tools rather than exposed directly, leaving notable gaps in transparency and direct source-level control.